AT337160B - Verfahren zur herstellung des neuen n-methyl-n-(3,4,5-trimethoxybenzyl)-2,3-dimethyl-2,4-pentadienamins und seinen saureadditionssalzen - Google Patents
Verfahren zur herstellung des neuen n-methyl-n-(3,4,5-trimethoxybenzyl)-2,3-dimethyl-2,4-pentadienamins und seinen saureadditionssalzenInfo
- Publication number
- AT337160B AT337160B AT181075A AT181075A AT337160B AT 337160 B AT337160 B AT 337160B AT 181075 A AT181075 A AT 181075A AT 181075 A AT181075 A AT 181075A AT 337160 B AT337160 B AT 337160B
- Authority
- AT
- Austria
- Prior art keywords
- pentadienamine
- trimethoxybenzyl
- dimethyl
- methyl
- preparing
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- MJFWGIGCSSZKIY-UHFFFAOYSA-N n,2,3-trimethyl-n-[(3,4,5-trimethoxyphenyl)methyl]penta-2,4-dien-1-amine Chemical compound COC1=CC(CN(C)CC(C)=C(C)C=C)=CC(OC)=C1OC MJFWGIGCSSZKIY-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT479676A AT340924B (de) | 1974-05-04 | 1976-06-30 | Verfahren zur herstellung des neuen 1,3,4-trimethyl-1- (3',4',5'-trimethoxybenzyl)- 1,2,5,6-tetrahydropyridiniumchlorids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES425970A ES425970A1 (es) | 1974-05-04 | 1974-05-04 | Un procedimiento para la obtencion de n - metil - n-(3,4,5-trimeboxibencil)-2,3-dimetil-2,4-pentadienamina. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA181075A ATA181075A (de) | 1976-10-15 |
| AT337160B true AT337160B (de) | 1977-06-10 |
Family
ID=8466594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT181075A AT337160B (de) | 1974-05-04 | 1975-03-07 | Verfahren zur herstellung des neuen n-methyl-n-(3,4,5-trimethoxybenzyl)-2,3-dimethyl-2,4-pentadienamins und seinen saureadditionssalzen |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5337337B2 (enExample) |
| AR (1) | AR206623A1 (enExample) |
| AT (1) | AT337160B (enExample) |
| AU (1) | AU8050775A (enExample) |
| BE (1) | BE828240A (enExample) |
| CA (1) | CA1052794A (enExample) |
| CH (1) | CH615150A5 (enExample) |
| DE (1) | DE2518534A1 (enExample) |
| ES (1) | ES425970A1 (enExample) |
| FR (1) | FR2269336B1 (enExample) |
| GB (1) | GB1501153A (enExample) |
| NL (1) | NL7505254A (enExample) |
| SE (1) | SE412755B (enExample) |
| SU (1) | SU562192A3 (enExample) |
-
1974
- 1974-05-04 ES ES425970A patent/ES425970A1/es not_active Expired
-
1975
- 1975-01-01 AR AR257859A patent/AR206623A1/es active
- 1975-03-07 AT AT181075A patent/AT337160B/de not_active IP Right Cessation
- 1975-04-15 SE SE7504301A patent/SE412755B/xx unknown
- 1975-04-15 GB GB15514/75A patent/GB1501153A/en not_active Expired
- 1975-04-22 BE BE155654A patent/BE828240A/xx unknown
- 1975-04-24 AU AU80507/75A patent/AU8050775A/en not_active Expired
- 1975-04-25 DE DE19752518534 patent/DE2518534A1/de active Pending
- 1975-04-30 FR FR7513536A patent/FR2269336B1/fr not_active Expired
- 1975-05-01 CA CA226,057A patent/CA1052794A/en not_active Expired
- 1975-05-02 CH CH568075A patent/CH615150A5/de not_active IP Right Cessation
- 1975-05-02 NL NL7505254A patent/NL7505254A/xx not_active Application Discontinuation
- 1975-05-02 JP JP5380075A patent/JPS5337337B2/ja not_active Expired
- 1975-05-04 SU SU2129803A patent/SU562192A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| FR2269336B1 (enExample) | 1977-09-09 |
| SU562192A3 (ru) | 1977-06-15 |
| JPS50151835A (enExample) | 1975-12-06 |
| FR2269336A1 (enExample) | 1975-11-28 |
| DE2518534A1 (de) | 1975-11-13 |
| ATA181075A (de) | 1976-10-15 |
| CA1052794A (en) | 1979-04-17 |
| AU8050775A (en) | 1976-10-28 |
| BE828240A (fr) | 1975-10-22 |
| JPS5337337B2 (enExample) | 1978-10-07 |
| ES425970A1 (es) | 1976-09-16 |
| NL7505254A (nl) | 1975-11-06 |
| CH615150A5 (en) | 1980-01-15 |
| GB1501153A (en) | 1978-02-15 |
| SE7504301L (sv) | 1975-11-05 |
| SE412755B (sv) | 1980-03-17 |
| AR206623A1 (es) | 1976-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT333759B (de) | Verfahren zur herstellung von neuen 3-subst.-4-phenylpiperidinen und von deren salzen | |
| ATA74575A (de) | Verfahren zur herstellung von neuen d,l-n-acyltyrosinamiden | |
| ATA904575A (de) | Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen | |
| AT343665B (de) | Verfahren zur herstellung von neuen n4-substituierten 1,4-benzodiazepin-2-on-derivaten | |
| AT330752B (de) | Verfahren zur herstellung des neuen n,n' -dichlorterephthalsaureamids und des n,n' -dichlor-isophthalsaureamids | |
| AT321886B (de) | Verfahren zur herstellung des neuen n-2,4-dimethylphenyl-n'-methylformamidins und seiner säureadditionssalze | |
| AT323756B (de) | Verfahren zur herstellung des neuen n-(1,1-diphosphonoäthyl)-acetamidins | |
| ATA823175A (de) | Verfahren zur herstellung des neuen 3,7-dimethyl-3-acetoxy-6-octensaurenitrils | |
| AT344702B (de) | Verfahren zur herstellung von neuen chinoxalin-1,4-dioxyd-derivaten | |
| AT337160B (de) | Verfahren zur herstellung des neuen n-methyl-n-(3,4,5-trimethoxybenzyl)-2,3-dimethyl-2,4-pentadienamins und seinen saureadditionssalzen | |
| ATA565776A (de) | Verfahren zur herstellung des neuen fortimicin c und seiner salze | |
| AT362378B (de) | Verfahren zur herstellung des neuen 3-cyan-n- -(n,n-dimethylaminopropyl)-iminodibenzyls und dessen saeureadditionssalzen | |
| ATA648674A (de) | Verfahren zur herstellung von neuen 1-acyl-1- (1,3,4-thiadiazolyl)-harnstoffen | |
| AT334872B (de) | Verfahren zur herstellung von neuen substituierten 4,4'-diaminodicyclohexylalkanen | |
| ATA150775A (de) | Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens | |
| ATA823075A (de) | Verfahren zur herstellung des neuen 3,7-dimethyl-3-hydroxy-6-octensaurenitrils | |
| AT339281B (de) | Verfahren zur herstellung von neuen 1-aryloxy-2-hydroxy-4-sek.aminobutanen und deren nichttoxischen saureadditionssalzen | |
| AT326837B (de) | Verfahren zur herstellung von neuen 2,2'-anhydro-1-beta-d-arabinofuranosyl-5-fluorcytosin-hydrofluorid, -hydrochlorid oder -hydrobromid | |
| AT330737B (de) | Verfahren zur herstellung von n-cyclohexyl-n-methyl-2-amino-3,5-dibrombenzylamin und dessen saureadditionssalzen | |
| AT339297B (de) | Verfahren zur herstellung von neuen 5,7-disubstituierten xanthon-2-carbonsaurederivaten | |
| AT337184B (de) | Verfahren zur herstellung von 1,2-dihydro-2-oxo-4-methyl-7-amino-chinolin und des neuen 1,2-dihydro-2-oxo-4-methyl-7-acetoacetylamino-chinolins | |
| ATA744974A (de) | Verfahren zur herstellung des neuen 2,3-dihydro-3-oxo-thieno(3,4-d)isothiazol-1,1-dioxids und seiner salze | |
| ATA744874A (de) | Verfahren zur herstellung des neuen 2,3-dihydro-3-oxo-thieno(2,3-d)isothiazol-1,1-dioxids und seiner salze | |
| AT342065B (de) | Verfahren zur herstellung von neuen 3- (5-nitro-1-methyl-2-imidazolyl)-s-triazolo (4,3-b)-pyridazinen und von deren salzen | |
| ATA729676A (de) | Verfahren zur herstellung von neuen 1-aryloxy-2-hydroxy-4-sek.aminobutanen und deren nichttoxischen saureadditionssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| UEP | Publication of translation of european patent specification |